Table 1 peripheral CD8 + T cells in patients of MG with and without treatment

Machi 1988

MG

Total

39.9 ± 8.0

1.34 ± 0.43

N/A

None

MG

Non-Tx

39.6 ± 7.4

1.41 ± 0.42

N/A

None

MG

Tx

40.2 ± 9.3

1.24 ± 0.45

N/A

None

HC

None

39.2 ± 5.5

1.40 ± 0.34

N/A

N/A

Kawanami 1990

MG

Total

N/A

N/A

N/A

N/A

MG

None

29.7 ± 3.0

1.2 ± 0.16

N/A

N/A

MG

Tx(− )PSL( +)

26.5 ± 2.1

1.3 ± 0.18

N/A

N/A

MG

Tx( +) PSL( − )

25.8 ± 3.5

1.7 ± 0.31

N/A

N/A

MG

Tx( +) PSL( +)

29.6 ± 1.1

0.94 ± 0.24

N/A

N/A

HC Female

None

26.8 ± 1.7

1.5 ± 0.1

N/A

N/A

HC male

None

28.4 ± 1.4

1.3 ± 0.1

N/A

N/A

Shimizu 1990

MG

Total

28.0 ± 10.5

1.8 ± 1.0

CD8 + CD11 + , CD8 + CD11−

CD8 + CD11 + , CD8 + CD11−

MG

Tx( +) PSL( − )

22.8 ± 4.3

2.2 ± 0.8

CD8 + CD11 + , CD8 + CD11−

CD8 + CD11 + , CD8 + CD11-

MG

Tx( − )PSL( +)

30.8 ± 12.6

1.5 ± 1.0

CD8 + CD11 + , CD8 + CD11−

CD8 + CD11 + , CD8 + CD11-

MG

Tx( +) PSL( − )

25.2 ± 6.5

2.1 ± 0.9

CD8 + CD11 + , CD8 + CD11−

CD8 + CD11 + , CD8 + CD11-

MG

Tx( +) PSL( +)

30.2 ± 12.1

1.7 ± 1.2

CD8 + CD11 + , CD8 + CD11−

CD8 + CD11 + , CD8 + CD11−

Fujii 1991

MG group A

Tx( +) PSL( +)

39.3 ± 9.2

1.23 ± 0.36

N/A

N/A

MG group B

Tx( +) PSL( − )

33.3 ± 13.6

1.89 ± 0.70

N/A

N/A

HC

None

39.2 ± 5.5

1.40 ± 0.34

N/A

N/A

Tanaka 2009

MG

Tx( +)

Mean 21

N/A

N/A

N/A

MG

None

Mean 14

N/A

N/A

N/A